Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Capital Employed: 2020-2023

Historic Return on Capital Employed for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to -0.31%.

  • ADC Therapeutics' Return on Capital Employed fell 5.00% to -0.31% in Q3 2023 from the same period last year, while for Sep 2023 it was -0.31%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.00% for FY2022, which is N/A change from last year.
  • ADC Therapeutics' Return on Capital Employed amounted to -0.31% in Q3 2023, which was down 34.36% from -0.23% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Capital Employed registered a high of -0.23% during Q2 2023, and its lowest value of -340.38% during Q3 2020.
  • In the last 3 years, ADC Therapeutics' Return on Capital Employed had a median value of -0.35% in 2022 and averaged -0.50%.
  • Per our database at Business Quant, ADC Therapeutics' Return on Capital Employed soared by 33,987bps in 2021 and then fell by 5bps in 2023.
  • Quarterly analysis of 4 years shows ADC Therapeutics' Return on Capital Employed stood at -340.38% in 2020, then spiked by 33,987bps to -0.81% in 2021, then surged by 55bps to -0.26% in 2022, then decreased by 5bps to -0.31% in 2023.
  • Its Return on Capital Employed was -0.31% in Q3 2023, compared to -0.23% in Q2 2023 and -0.31% in Q1 2023.